Literature DB >> 9215536

Particle size determines the specificity of apolipoprotein E-containing triglyceride-rich emulsions for the LDL receptor versus hepatic remnant receptor in vivo.

P C Rensen1, N Herijgers, M H Netscher, S C Meskers, M van Eck, T J van Berkel.   

Abstract

Apolipoprotein E (apoE) is an important determinant for the uptake of triglyceride-rich emulsions and lipoproteins by the liver, and exerts affinity for both the LDL receptor (LDLr) and a distinct liver-specific recognition site. Our current aim was to assess the mechanism underlying the receptor-specificity of apoE-carrying lipoproteins. Triglyceride-rich emulsions were synthesized, with mean sizes of 50, 80, and 150 nm. These fractions efficiently acquired apoE from rat serum, and were processed by LPL in vivo with a similar efficiency. Upon injection of the [5H]cholesteryl oleate-labeled emulsions into rats, the liver association rate was positively correlated with particle size (24 +/- 2%, 54 +/- 1%, and 64 +/- 3% of the injected dose at 20 min after injection, respectively) and the liver uptake was predominantly exerted by parenchymal cells. The role of the LDLr in emulsion clearance was established in wild-type versus LDLr knockout mice. In the absence of the LDLr, an 8-fold increased serum half-life was observed for the small emulsion, concomitant with a 6- and 15-fold decreased uptake by the liver and adrenals at 60 min after injection, respectively. In contrast, the in vivo behavior of the large emulsion was independent of the LDLr. Both the ratio of apoE:C on the emulsions upon serum incubation and the alpha-helical content of apoE were inversely correlated with particle size, indicating that these factors may be involved in the emulsion size-dependent receptor specificity in vivo. It is concluded that the contribution of the LDLr to the apoE-mediated clearance of emulsions by the liver and adrenals strongly increases with decreasing particle size, while large particles initially associate with a distinct liver-specific recognition site. As these emulsions mimic chylomicrons, we anticipate that the apoE-dependent metabolic behavior of chylomicrons (remnants) is largely dependent on their size.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9215536

Source DB:  PubMed          Journal:  J Lipid Res        ISSN: 0022-2275            Impact factor:   5.922


  35 in total

1.  Fenofibrate increases very low density lipoprotein triglyceride production despite reducing plasma triglyceride levels in APOE*3-Leiden.CETP mice.

Authors:  Silvia Bijland; Elsbet J Pieterman; Annemarie C E Maas; José W A van der Hoorn; Marjan J van Erk; Jan B van Klinken; Louis M Havekes; Ko Willems van Dijk; Hans M G Princen; Patrick C N Rensen
Journal:  J Biol Chem       Date:  2010-05-25       Impact factor: 5.157

2.  Apolipoprotein CI enhances the biological response to LPS via the CD14/TLR4 pathway by LPS-binding elements in both its N- and C-terminal helix.

Authors:  Jimmy F P Berbée; Claudia P Coomans; Marit Westerterp; Johannes A Romijn; Louis M Havekes; Patrick C N Rensen
Journal:  J Lipid Res       Date:  2010-03-24       Impact factor: 5.922

3.  Real-time magnetic resonance imaging and quantification of lipoprotein metabolism in vivo using nanocrystals.

Authors:  Oliver T Bruns; Harald Ittrich; Kersten Peldschus; Michael G Kaul; Ulrich I Tromsdorf; Joachim Lauterwasser; Marija S Nikolic; Birgit Mollwitz; Martin Merkel; Nadja C Bigall; Sameer Sapra; Rudolph Reimer; Heinz Hohenberg; Horst Weller; Alexander Eychmüller; Gerhard Adam; Ulrike Beisiegel; Joerg Heeren
Journal:  Nat Nanotechnol       Date:  2009-01-25       Impact factor: 39.213

Review 4.  Dietary factors in atherogenesis.

Authors:  Margaret-Mary G Wilson; David R Thomas
Journal:  Curr Atheroscler Rep       Date:  2003-07       Impact factor: 5.113

5.  Synthesis of a lipophilic daunorubicin derivative and its incorporation into lipidic carriers developed for LDL receptor-mediated tumor therapy.

Authors:  A J Versluis; E T Rump; P C Rensen; T J Van Berkel; M K Bijsterbosch
Journal:  Pharm Res       Date:  1998-04       Impact factor: 4.200

6.  CETP does not affect triglyceride production or clearance in APOE*3-Leiden mice.

Authors:  Silvia Bijland; Sjoerd A A van den Berg; Peter J Voshol; Anita M van den Hoek; Hans M G Princen; Louis M Havekes; Patrick C N Rensen; Ko Willems van Dijk
Journal:  J Lipid Res       Date:  2010-01       Impact factor: 5.922

7.  Prolonged daily light exposure increases body fat mass through attenuation of brown adipose tissue activity.

Authors:  Sander Kooijman; Rosa van den Berg; Ashna Ramkisoensing; Mariëtte R Boon; Eline N Kuipers; Marieke Loef; Tom C M Zonneveld; Eliane A Lucassen; Hetty C M Sips; Iliana A Chatzispyrou; Riekelt H Houtkooper; Johanna H Meijer; Claudia P Coomans; Nienke R Biermasz; Patrick C N Rensen
Journal:  Proc Natl Acad Sci U S A       Date:  2015-05-11       Impact factor: 11.205

8.  Trans-intestinal cholesterol efflux is not mediated through high density lipoprotein.

Authors:  Carlos L J Vrins; Roelof Ottenhoff; Karin van den Oever; Dirk R de Waart; J Kar Kruyt; Ying Zhao; Theo J C van Berkel; Louis M Havekes; Johannes M Aerts; Miranda van Eck; Patrick C N Rensen; Albert K Groen
Journal:  J Lipid Res       Date:  2012-07-16       Impact factor: 5.922

9.  Hepatic RNA Interference: Delivery by Synthetic Vectors.

Authors:  Matthew Haynes; Leaf Huang
Journal:  Drug Deliv Transl Res       Date:  2014-02-01       Impact factor: 4.617

10.  Increased expression of apolipoprotein E in transgenic rabbits results in reduced levels of very low density lipoproteins and an accumulation of low density lipoproteins in plasma.

Authors:  J Fan; Z S Ji; Y Huang; H de Silva; D Sanan; R W Mahley; T L Innerarity; J M Taylor
Journal:  J Clin Invest       Date:  1998-05-15       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.